ProAssurance (NYSE:PRA – Get Free Report) will be posting its quarterly earnings results after the market closes on Monday, May 6th. Analysts expect ProAssurance to post earnings of $0.04 per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.
ProAssurance (NYSE:PRA – Get Free Report) last posted its quarterly earnings results on Tuesday, February 27th. The insurance provider reported ($0.05) earnings per share for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.09). The business had revenue of $296.96 million for the quarter, compared to the consensus estimate of $252.74 million. ProAssurance had a negative return on equity of 0.53% and a negative net margin of 3.39%. The company’s quarterly revenue was up .8% on a year-over-year basis. During the same period last year, the firm earned $0.06 earnings per share. On average, analysts expect ProAssurance to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.
ProAssurance Trading Down 3.5 %
PRA opened at $13.17 on Monday. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.27 and a quick ratio of 0.27. The company has a market cap of $671.27 million, a price-to-earnings ratio of -17.80 and a beta of 0.24. The firm has a 50 day simple moving average of $12.80 and a 200 day simple moving average of $13.72. ProAssurance has a fifty-two week low of $11.76 and a fifty-two week high of $19.38.
Wall Street Analyst Weigh In
View Our Latest Analysis on ProAssurance
ProAssurance Company Profile
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.
Featured Articles
- Five stocks we like better than ProAssurance
- The Most Important Warren Buffett Stock for Investors: His Own
- Snap Crackles and Pops on Surprise Profit and Raised Guidance
- Find and Profitably Trade Stocks at 52-Week Lows
- MarketBeat Week in Review – 4/22 – 4/26
- Consumer Discretionary Stocks Explained
- 3 Stocks Leading the U.S. Agriculture Comeback
Receive News & Ratings for ProAssurance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProAssurance and related companies with MarketBeat.com's FREE daily email newsletter.